| CTRI Number |
CTRI/2025/07/090812 [Registered on: 14/07/2025] Trial Registered Prospectively |
| Last Modified On: |
06/06/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
To Study the Efficacy of Bruhata Shatavari Ghrita in the Management of Rajonivrutti with Special Reference to Peri-Menopausal Syndrome
|
|
Scientific Title of Study
|
OPEN LABELLED RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF BRUHATA SHATAVARI GHRITA IN THE MANAGEMENT OF RAJONIVRUTTI W.S.R TO PERI MENOPAUSAL SYNDROME |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Snehal Suryakant Panjarale |
| Designation |
PG Scholor |
| Affiliation |
SST Ayurved Mahavidyalaya, Sangamner |
| Address |
opd no 1 prasutitantra and strirog department ground floor sst ayurved college Front of prasad hotel, pune-nashik highway, Sangamner
Ahmadnagar
MAHARASHTRA
422605
India
Ahmadnagar MAHARASHTRA 422605 India |
| Phone |
9423497110 |
| Fax |
|
| Email |
snehal.panjarale@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Snehal Suryakant Panjarale |
| Designation |
PG Scholor |
| Affiliation |
SST Ayurved Mahavidyalaya, Sangamner |
| Address |
opd no 1 prasutitantra and strirog department ground floor sst ayurved college Front of prasad hotel, pune-nashik highway, Sangamner
Ahmadnagar
MAHARASHTRA
422605
India
Ahmadnagar MAHARASHTRA 422605 India |
| Phone |
9423497110 |
| Fax |
|
| Email |
snehal.panjarale@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Amit Shinde |
| Designation |
HOD Striroga Prasuti Tantra Department |
| Affiliation |
SST Ayurved Mahavidhyala , Sangamner |
| Address |
OPD no 1 Prasuti Tantra and Stri Roga OPD Ground Floor SST
Ayurved Medical college Sangamner Dist Ahmadnagar
Ahmadnagar
MAHARASHTRA
422605
India
Ahmadnagar MAHARASHTRA 422605 India |
| Phone |
09881303593 |
| Fax |
|
| Email |
amitshinde112@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dr Snehal Suryakant Panjarale |
| Address |
sangam sevabhavi trust ayurved mahavidyalaya sangamner
ghulewadi dist ahmadnagar 422605 |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Snehal Suryakant Panjarale |
SST Ayurved Mahavidyalaya, Sangamner |
OPD no 1 Prasuti Tantra and Stri Roga OPD Ground Floor SST
Ayurved Medical college Sangamner Dist Ahmadnagar
Ahmadnagar
MAHARASHTRA
422605
India Ahmadnagar MAHARASHTRA |
9423497110
snehal.panjarale@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N958||Other specified menopausal and perimenopausal disorders. Ayurveda Condition: RAJONASAH (KEVALAVATA), |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: BRUHATA SHATAVARI GHRITA, Reference: Charak Samhita, Route: Oral, Dosage Form: Ghrita, Dose: 20(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -warm water), Additional Information: - | | 2 | Comparator Arm (Non Ayurveda) | | - | Tab Premarin | Estrogen therapy
Short term Hormone Replacement Therapy[HRT]
Tab. Premarin [0.625 mg]
1 tablet is taken orallay as bed time from 1st to 20th day of a month for 3 months.
If patient is premenopausal with irregular bleeding will be given p4 to p24 menstrual cycle |
|
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Female |
| Details |
Appearance of peri-menopausal syndrome. i.e.
Hot flushes ( Daha Prachiti )
Excessive sweating (Prabhuta Swedata)
Backache (Katishoola)
Sleep disturbances ( Asamyaka Nidra )
Dryness of vagina12 ( Yonishushkata )
|
|
| ExclusionCriteria |
| Details |
Diagnosed patients of Diabetes and Hypertension.
Pre-existing Psychological disorder or any systemic disease. uterine prolapsed cancer.
Patients who had undergone hysterectomy.
|
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| to relief of peri-menopausal syndrome |
to relief of peri-menopausal syndrome in 3 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| bruhata shatavari ghrita is significantly effective in management of Rajanivrutti w.s.r. to Peri-menopausal syndronme |
3 months |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
29/07/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
it is a open labelled randomized controlled trial to evaluate the efficacy of bruhata shatavari ghrita in the management of rajonivrutti with respect to peri-menopausal syndrome in 40 to 50 years old female |